Descriptive epidemiology of Escherichia coli bacteraemia in England, april 2012 to march 2014

Eurosurveillance

Volumn 21, Issue 35, 2016, Pages

  Bou Antoun, S ^a   Davies, John ^a   Guy, R ^a   Johnson, A P ^a   Sheridan, E A ^a   Hope, R J ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DISEASE SURVEILLANCE; ESCHERICHIA COLI INFECTION; FEMALE; GASTROINTESTINAL INFECTION; GRAM NEGATIVE SEPSIS; HEPATOBILIARY SYSTEM INFECTION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH SERVICE; NEWBORN; RESPIRATORY TRACT INFECTION; SOFT TISSUE INFECTION; UNITED KINGDOM; URINARY TRACT INFECTION; VERY ELDERLY; BACTEREMIA; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG EFFECTS; ENGLAND; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HEALTH SURVEY; INCIDENCE; ISOLATION AND PURIFICATION; MANDATORY REPORTING; PRESCHOOL CHILD; RISK FACTOR; URINARY TRACT INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENGLAND; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MANDATORY REPORTING; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 85015355169     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.35.30329     Document Type: Article

References (35)

1. Public Health England (PHE). Health Protection Report: Voluntary surveillance of Escherichia coli bacteraemia in England, Wales and Northern Ireland: 2009-2013. London: PHE; 16 May 2014. [Accessed January 2015]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/339992/Ecoli_bacteraemia_in_Eng_Wales_and_NI_2009_to_2013.pdf
2. Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gur D, et al.. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill. 2011;16(11):19819.PMID: 21435327
3. Berger J, Diab-Elschahawi M, Blacky A, Pernicka E, Spertini V, Assadian O, et al. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance. Am J Infect Control. 2010;38(10):839-45.DOI: 10.1016/j.ajic.2010.04.212 PMID: 20650546
4. Bo S-N, Bo J, Ning Y-Z, Zhao Y, Lu X-L, Yang J-Y, et al. Relationship between time to positivity of blood culture with clinical characteristics and hospital mortality in patients with Escherichia coli bacteremia. Chin Med J (Engl). 2011;124(3):330-4.PMID: 21362328
5. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR, St Sauver JL, Wilson WR, et al. Age-and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med. 2007;167(8):834-9.DOI: 10.1001/archinte.167.8.834 PMID: 17452548
6. Abernethy JK, Johnson AP, Guy R, Hinton N, Sheridan EA, Hope RJ. Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England. Clin Microbiol Infect. 2015;21(3):251.e1-8.DOI: 10.1016/j.cmi.2015.01.001 PMID: 25698659
7. Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.J Infect. 2007;55(3):254-9.DOI: 10.1016/j.jinf.2007.04.007 PMID: 17574678
8. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82-9.DOI: 10.1086/499406 PMID: 16355321
9. Office for National Statistics (ONS). Population Estimates for UK, England and Wales, Scotland and Northern Ireland, Mid-2011 and Mid-2012 2013. Updated 08/08/20132014. London: ONS. Available from: http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk--england-and-wales--scotland-and-northern-ireland/mid-2011-and-mid-2012/index.html
10. England National Health Service (NHS England). KH03: Bed Availability and Occupancy Data-Overnight. NHS Organisations in England for 2012-14. Leeds: NHS England; 2014. Available from: https://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/bed-data-overnight/
11. Health and Social Care Information Centre (HSCIC). ERIC-Estates Return Information Collection: 2012-13 Data return. Leeds: HSCIC; 2014, [Accessed August 2014]. Available from: http://hefs.hscic.gov.uk/DataFiles.asp
12. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, Golan Y, Noy A, Schwartz D, et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis. 2002;34(11):1431-9.DOI: 10.1086/339809 PMID: 12015688
13. Livermore DM, Hope R, Reynolds R, Blackburn R, Johnson AP, Woodford N. Declining cephalosporin and fluoroquinolone nonsusceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother. 2013;68(11):2667-74.DOI: 10.1093/jac/dkt212 PMID: 23766490
14. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Seasonal variation in Escherichia coli bloodstream infection: a population-based study. Clin Microbiol Infect. 2009;15(10):947-50.DOI: 10.1111/j.1469-0691.2009.02877.x PMID: 19845704
15. Deeny SR, van Kleef E, Bou-Antoun S, Hope RJ, Robotham JV. Seasonal changes in the incidence of Escherichia coli bloodstream infection: variation with region and place of onset. Clin Microbiol Infect. 2015;21(10):924-9.DOI: 10.1016/j. cmi.2015.06.023 PMID: 26141255
16. Whitehead M, Doran T. The north-south health divide. BMJ. 2011;342(feb15 2):d584.DOI: 10.1136/bmj.d584 PMID: 21325006
17. Kennedy KJ, Roberts JL, Collignon PJ. Escherichia coli bacteraemia in Canberra: incidence and clinical features. Med J Aust. 2008;188(4):209-13.PMID: 18279126
18. Laupland KB, Gregson DB, Church DL, Ross T, Pitout JDD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect. 2008;14(11):1041-7.DOI: 10.1111/j.1469-0691.2008.02089.x PMID: 19040476
19. Laupland KB, Gregson DB, Flemons WW, Hawkins D, Ross T, Church DL. Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect. 2007;135(6):1037-42.DOI: 10.1017/S0950268806007631 PMID: 17156500
20. Williamson DA, Lim A, Wiles S, Roberts SA, Freeman JT. Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005-2011. BMC Infect Dis. 2013;13(1):385.DOI: 10.1186/1471-2334-13-385 PMID: 23964864
21. Holt PG, Jones CA. The development of the immune system during pregnancy and early life. Allergy. 2000;55(8):688-97.DOI: 10.1034/j.1398-9995.2000.00118.x PMID: 10955693
22. Weng N-P. Aging of the immune system: how much can the adaptive immune system adapt? Immunity. 2006;24(5):495-9.DOI: 10.1016/j.immuni.2006.05.001 PMID: 16713964
23. Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al.. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127(5):817-26.DOI: 10.1542/peds.2010-2217 PMID: 21518717
24. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49(2):53-70.DOI: 10.1067/mda.2003.7 PMID: 12601337
25. Nielsen SL, Pedersen C, Jensen TG, Gradel KO, Kolmos HJ, Lassen AT. Decreasing incidence rates of bacteremia: a 9-year population-based study. J Infect. 2014;69(1):51-9.DOI: 10.1016/j.jinf.2014.01.014 PMID: 24576825
26. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791-7.DOI: 10.7326/0003-4819-137-10-200211190-00007 PMID: 12435215
27. Rafferty AM, Clarke SP, Coles J, Ball J, James P, McKee M, et al. Outcomes of variation in hospital nurse staffing in English hospitals: cross-sectional analysis of survey data and discharge records. Int J Nurs Stud. 2007;44(2):175-82.DOI: 10.1016/j.ijnurstu.2006.08.003PMID: 17064706
28. Kanerva M, Ollgren J, Lyytikainen O, Finnish Prevalence Survey Study Group. Interhospital differences and case-mix in a nationwide prevalence survey. J Hosp Infect. 2010;76(2):135-8.DOI: 10.1016/j.jhin.2010.05.017 PMID: 20663587
29. Factors Contributing to the Emergence of Resistance. In: Knobler SL, Lemon SM, Najafi M, et al., editors. The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment: Workshop Summary. Washington (DC): National Academies Press (US); 2003.
30. Bos MMEM, Smeets LS, Dumay I, de Jonge E. Bloodstream infections in patients with or without cancer in a large community hospital. Infection. 2013;41(5):949-58.DOI: 10.1007/s15010-013-0468-1 PMID: 23645474
31. Ha YE, Kang C-I, Cha MK, Park SY, Wi YM, Chung DR, et al. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamaseproducing Escherichia coli in patients with cancer. Int J Antimicrob Agents. 2013;42(5):403-9.DOI: 10.1016/j.ijantimicag.2013.07.018 PMID: 24071027
32. Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, et al., COLIBAFI Group. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect. 2011;17(4):557-65.DOI: 10.1111/j.1469-0691.2010.03298.x PMID: 20649802
33. Public Health England (PHE). English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) 2014. London: PHE. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/362374/ESPAUR_Report_2014__3_.pdf
34. Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother. 2001;47(6):781-7.DOI: 10.1093/jac/47.6.781 PMID: 11389110
35. Rodríguez-Bano J, Navarro MD, Romero L, Muniain MA, de Cueto M, Galvez J, et al. Risk-factors for emerging bloodstream infections caused by extended-spectrum betalactamase-producing Escherichia coli. Clin Microbiol Infect. 2008;14(2):180-3.DOI: 10.1111/j.1469-0691.2007.01884.x PMID: 18005358